Literature DB >> 17120980

A SPINK1 gene mutation in a Thai patient with fibrocalculous pancreatic diabetes.

Thiti Snabboon1, Wanee Plengpanich, Vitaya Sridama, Sarat Sunthornyothin, Sompongse Suwanwalaikorn, Weerapan Khovidhunkit.   

Abstract

Fibrocalculous pancreatitis diabetes (FCPD), a late stage of tropical chronic pancreatitis (TCP), is classified as a secondary cause of diabetes mellitus resulting from pancreatic exocrine dysfunction. The distinctive features of FCPD and TCP are young age at onset, presence of large intraductal pancreatic calculi, and reported mainly in tropical developing countries. Their etiology is still obscure, but the autodigestion due to aberrant intraductal activation of zymogens by trypsin is thought to be a primary common event. Recently, mutations in SPINKI gene encoding a pancreatic secretory trypsin inhibitor have been reported in association with an increased risk of pancreatitis. We describe a heterozygous mutation, IVS3+2 T>C, of SPINK1 gene in a young Thai female patient with typical presentation of FCPD. To our knowledge, this is the first report of the SPINK1 gene mutation in a FCPD patient in Southeast Asia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17120980

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  3 in total

1.  Minigene analysis of intronic variants in common SPINK1 haplotypes associated with chronic pancreatitis.

Authors:  E Kereszturi; O Király; M Sahin-Tóth
Journal:  Gut       Date:  2008-10-31       Impact factor: 23.059

2.  Frequency of CFTR, SPINK1, and cathepsin B gene mutation in North Indian population: connections between genetics and clinical data.

Authors:  Shweta Singh; Gourdas Choudhuri; Sarita Agarwal
Journal:  ScientificWorldJournal       Date:  2014-01-27

Review 3.  Genetic aspects of tropical calcific pancreatitis.

Authors:  Heiko Witt; Eesh Bhatia
Journal:  Rev Endocr Metab Disord       Date:  2008-09       Impact factor: 9.306

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.